acquired
Stage
5
Investors
About
Bluejay Therapeutics is a clinical-stage biopharmaceutical company focused on developing potentially life-changing therapeutics for serious viral and liver diseases, primarily chronic hepatitis B and chronic hepatitis D.
Explore Bluejay Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.